keyword
https://read.qxmd.com/read/38685716/hydralazine-use-can-be-associated-with-igm-dominated-immune-complex-mediated-glomerulonephritis
#1
JOURNAL ARTICLE
Ping L Zhang, Brandon D Metcalf, Sarang Khan, Jamal Abukhaled, Khalid Zafar, Wei Li, Hassan D Kanaan
CONTEXT: IgM-dominant immune complex-mediated glomerulonephritis (IgM-dominant ICMGN) is a rare renal entity, characterized by a membranoproliferative pattern by light microscopy, dominant IgM staining by immunofluorescent staining, and subendothelial deposits by electron microscopy. This study was to investigate if some of IgM-ICMGN were associated with autoimmune disorders induced by hydralazine. DESIGN: Seven IgM-dominant ICMGN cases were identified over 8 years...
April 29, 2024: Ultrastructural Pathology
https://read.qxmd.com/read/38662234/clinical-characteristics-and-outcomes-of-immune-complex-membranoproliferative-glomerulonephritis-and-c3-glomerulopathy-in-japanese-children
#2
JOURNAL ARTICLE
Chika Ueda, Tomoko Horinouchi, Yuta Inoki, Yuta Ichikawa, Yu Tanaka, Hideaki Kitakado, Atsushi Kondo, Nana Sakakibara, China Nagano, Tomohiko Yamamura, Junya Fujimura, Naohiro Kamiyoshi, Shingo Ishimori, Takeshi Ninchoji, Hiroshi Kaito, Yuko Shima, Kazumoto Iijima, Kandai Nozu, Norishige Yoshikawa
BACKGROUND: Membranoproliferative glomerulonephritis (MPGN) can be divided into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G), which includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). These conditions result from abnormalities in different complement pathways and may lead to different prognoses. However, there are limited studies describing the respective clinical courses. METHODS: In this study, Japanese pediatric patients diagnosed with MPGN based on kidney biopsies conducted between February 2002 and December 2022 were reclassified as having IC-MPGN or C3G (DDD or C3GN)...
April 25, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38649219/liver-disease-associated-glomerulopathies
#3
REVIEW
Swetha R Kanduri, Yonatan Peleg, Shikha Wadhwani
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infect a significant number of individuals globally and their extra-hepatic manifestations, including glomerular disease, are well established. Additionally, liver disease-associated IgA nephropathy is the leading cause of secondary IgA nephropathy with disease course varying from asymptomatic urinary abnormalities to progressive kidney injury. Herein we provide an updated review on the epidemiology, pathogenesis, clinical manifestations, and treatment of HBV- and HCV-related glomerulonephritis as well as IgA nephropathy in patients with liver disease...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38624051/the-diagnostic-significance-of-c4d-deposits-as-an-immunohistochemical-proof-of-complement-activation-in-kidney-glomerular-pathologies-and-kidney-transplantation
#4
REVIEW
Stanislav Hresko, Martina Madarova, Miroslava Dobosova, Nikola Palusekova, Petra Niznerova, Stanislav Ziaran, Ivan Varga
C4d, a split product of C4 activation in classical and lectin pathways of the complement system activation, has been regarded as a footprint of tissue damage in antibody-mediated rejection in transplantology. The introduction of C4d staining into daily clinical practice aroused an ever-increasing interest in the role of antibody-mediated mechanisms in kidney allograft rejection. However, this marker of complement activation is also important in other various kidney glomerular pathologies such as immunoglobulin A nephropathy, membranoproliferative glomerulonephritis, lupus nephritis, and others...
2024: Bratislavské Lekárske Listy
https://read.qxmd.com/read/38623264/kidney-histopathology-of-patients-with-hepatitis-c-infection-and-diabetes-mellitus-before-and-after-availability-of-direct-acting-antiviral-therapy
#5
JOURNAL ARTICLE
Vanderlene L Kung, Gabriel Giannini, Cynthia C Nast
INTRODUCTION: Type 2 diabetes mellitus (DM) and diabetic kidney disease are increasing. Hepatitis C infection (HCV) occurs in 1% of the world population and can induce several kidney diseases. DM prevalence is increased in individuals with HCV; however, kidney diseases in those with both DM and HCV have not been assessed. Direct-acting antiviral agents (DAAs) became available for HCV treatment in 2014; it is unknown if DAAs altered the spectrum of kidney disease in patients with DM and HCV...
2024: Glomerular diseases
https://read.qxmd.com/read/38598098/-nephropathology-of-infectious-disease
#6
REVIEW
Maike Büttner-Herold, Kerstin Amann, Joachim Velden
Infections can affect the kidney via different pathways. Urinary tract infections can directly involve the renal tissue by spreading along pre-existing canalicular structures. Such an ascending infection can manifest as a highly active and purulent or even abscessing interstitial nephritis or as a chronic-fibrosing process in recurrent pyelonephritis. Viral infections can also use the canalicular route as in polyomavirus nephropathy or spread via the blood stream in a hematogenous manner as in the case of cytomegalovirus or hantavirus infections...
April 10, 2024: Pathologie (Heidelb)
https://read.qxmd.com/read/38596269/exploring-kidney-biopsy-findings-in-congenital-heart-diseases-insights-beyond-cyanotic-nephropathy
#7
JOURNAL ARTICLE
Jose Daniel Juarez-Villa, Iván Zepeda-Quiroz, Sebastián Toledo-Ramírez, Victor Hugo Gomez-Johnson, Francisco Pérez-Allende, Brian Ricardo Garibay-Vega, Francisco E Rodríguez Castellanos, Bernardo Moguel-González, Edgar Garcia-Cruz, Salvador Lopez-Gil
BACKGROUND: The association between congenital heart disease and chronic kidney disease is well known. Various mechanisms of kidney damage associated with congenital heart disease have been established. The etiology of kidneydisease has commonly been considered to be secondary to focal segmental glomerulosclerosis (FSGS), however, this has only been demonstrated in case reports and not in observational or clinical trials. AIM: To identify baseline and clinical characteristics, as well as the findings in kidney biopsies of patients with congenital heart disease in our hospital...
March 25, 2024: World Journal of Nephrology
https://read.qxmd.com/read/38576387/diagnostic-challenges-and-emerging-pathogeneses-of-selected-glomerulopathies
#8
JOURNAL ARTICLE
Nicole K Andeen, Jean Hou
Recent progress in glomerular immune complex and complement-mediated diseases have refined diagnostic categories and informed mechanistic understanding of disease development in pediatric patients. Herein, we discuss selected advances in 3 categories. First, membranous nephropathy antigens are increasingly utilized to characterize disease in pediatric patients and include phospholipase A2 receptor (PLA2R), Semaphorin 3B (Sema3B), neural epidermal growth factor-like 1 (NELL1), and protocadherin FAT1, as well as the lupus membranous-associated antigens exostosin 1/2 (EXT1/2), neural cell adhesion molecule 1 (NCAM1), and transforming growth factor beta receptor 3 (TGFBR3)...
April 5, 2024: Pediatric and Developmental Pathology
https://read.qxmd.com/read/38398059/complement-activation-in-nephrotic-glomerular-diseases
#9
REVIEW
Dominik Nell, Robert Wolf, Przemyslaw Marek Podgorny, Tobias Kuschnereit, Rieke Kuschnereit, Thomas Dabers, Sylvia Stracke, Tilman Schmidt
The nephrotic syndrome holds significant clinical importance and is characterized by a substantial protein loss in the urine. Damage to the glomerular basement membrane or podocytes frequently underlies renal protein loss. There is an increasing belief in the involvement of the complement system, a part of the innate immune system, in these conditions. Understanding the interactions between the complement system and glomerular structures continually evolves, challenging the traditional view of the blood-urine barrier as a passive filter...
February 18, 2024: Biomedicines
https://read.qxmd.com/read/38358193/to-interpret-and-analyze-the-changing-patterns-of-histology-and-direct-immunofluorescence-findings-in-membranoproliferative-glomerulonephritis
#10
JOURNAL ARTICLE
Pragnya P Nayak, Pranati Pradhan, Dilleswari Pradhan, Nachiketa Mohapatra, Sarojini Raman, Pranabandhu Sahoo
BACKGROUND: Membranoproliferative glomerulonephritis has in the recent past been regrouped into immune complex-mediated (ICM MPGN) disease (driven by the classical complement pathway) and complement-mediated (C3GN) disease (driven by the alternative complement pathway) based on pathogenetic role of alternative complement pathway and immunofluorescence deposits. The proposed regrouping lent therapeutic and prognostic support in managing the disease of MPGN. AIMS AND OBJECTIVES: The present study is undertaken to study the patterns of MPGN based on histopathological and DIF examination and sub-categorize the cases into mainly complement dominant and immune complex-mediated diseases for better prognostic and therapeutic utility...
2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38343496/atypical-hemolytic-uremic-syndrome-a-nationwide-colombian-pediatric-series
#11
JOURNAL ARTICLE
Zilac Espitaleta, Alex Domínguez-Vargas, Johanna Villamizar-Martínez, Martha Carrascal-Guzmán, Gustavo Guerrero-Tinoco, Diana Silva-Díaz, Richard Baquero, Claudia Pinto-Bernal, Luz González-Chaparro, Luisa Rojas-Rosas, Pilar Amado-Niño, Mariángel Castillo-Arteaga, Yeferson Alvarez-Gómez, Laura Arguello-Muñoz, William Morales-Camacho, Oscar León-Guerra, Eduardo Egea, Ricardo Galeano-Rodríguez, Ana Quintero-Gómez, Gustavo Aroca-Martínez, Carlos G Musso
Objectives. Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric cohort to delineate disease presentation and outcomes. Methods. A multicenter cohort of 27 Colombian children with aHUS were included. Patients were grouped by age at onset. Clinical features were compared using analysis of variance (ANOVA) and Fisher exact tests...
2024: Global Pediatric Health
https://read.qxmd.com/read/38337366/implementation-of-kidney-biopsy-in-one-of-the-poorest-countries-in-the-world-experience-from-zinder-hospital-niger
#12
JOURNAL ARTICLE
Hassane Moussa Diongolé, Zeinabou Maiga Moussa Tondi, Abdoulazize Garba, Kabirou Ganiou, Laouali Chaibou, Djibrilla Bonkano, Illiassou Aboubacar, Abdoul Aziz Seribah, Abdoul Madjid Abdoulaye Idrissa, Akinfenwa Atanda, Lionel Rostaing
Kidney biopsy (KB) has become essential in the nephrologist's approach to kidney diseases, both for diagnosis, treatment, and prognosis. Our objective is to describe the preliminary results of KBs in Niger, one of the poorest countries in the world. This is a descriptive cross-sectional study that took place over 36 months in the nephrology/dialysis department of the Zinder National Hospital. Biopsy results were obtained in less than 5 working days. Patients were responsible for covering the cost of the kidney biopsy...
January 24, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38312795/iptacopan-in-idiopathic-immune-complex-mediated-membranoproliferative-glomerulonephritis-protocol-of-the-apparent-multicenter-randomized-phase-3-study
#13
JOURNAL ARTICLE
Marina Vivarelli, Andrew S Bomback, Matthias Meier, Yaqin Wang, Nicholas J A Webb, Uday Kiran Veldandi, Richard J H Smith, David Kavanagh
INTRODUCTION: Immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) is an ultra-rare, fast-progressing kidney disease that may be idiopathic (primary) or secondary to chronic infection, autoimmune disorders, or monoclonal gammopathies. Dysregulation of the alternative complement pathway is implicated in the pathophysiology of IC-MPGN; and currently, there are no approved targeted treatments. Iptacopan is an oral, highly potent proximal complement inhibitor that specifically binds to factor B and inhibits the alternative pathway (AP)...
January 2024: KI Reports
https://read.qxmd.com/read/38267800/rationale-and-design-of-the-japanese-biomarkers-in-nephrotic-syndrome-j-marine-study
#14
JOURNAL ARTICLE
Shimon Kurasawa, Sawako Kato, Takaya Ozeki, Shin'ichi Akiyama, Takuji Ishimoto, Masashi Mizuno, Naotake Tsuboi, Noritoshi Kato, Tomoki Kosugi, Shoichi Maruyama
INTRODUCTION: Disease subtyping and monitoring are essential for the management of nephrotic syndrome (NS). Although various biomarkers for NS have been reported, their clinical efficacy has not been comprehensively validated in adult Japanese patients. METHODS: The Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study is a nationwide, multicenter, and prospective cohort study in Japan, enrolling adult (≥18 years) patients with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), membranoproliferative glomerulonephritis (MPGN), C3 glomerulopathy (C3G), and lupus nephritis (LN)...
January 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38254040/a-case-of-unexpected-diagnosis-of-fibronectin-glomerulopathy-with-histological-features-of-membranoproliferative-glomerulonephritis
#15
JOURNAL ARTICLE
Misa Hata, Takayasu Mori, Yurika Hirose, Yuriko Nishida, Shintaro Mandai, Fumiaki Ando, Koichiro Susa, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Tatemitsu Rai, Towako Taguchi, Shohei Tomii, Kenichi Ohashi, Shinichi Uchida
Fibronectin (FN) glomerulopathy (FNG), a rare autosomal hereditary renal disease, is characterized by proteinuria resulting from the massive accumulation of FN in the glomeruli. It typically affects individuals aged 10-50 years. In this report, we describe the case of a 57-year-old man who was diagnosed with FNG through genetic analysis and histological examination that revealed membranoproliferative glomerulonephritis. Despite treatment with prednisolone, the therapeutic response was unsatisfactory. Prednisolone was subsequently tapered and discontinued because the patient had pulmonary thromboembolism...
January 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38252289/anti-factor-b-antibodies-in-atypical-hemolytic-uremic-syndrome
#16
JOURNAL ARTICLE
Priyanka Khandelwal, Shreesha Nambiar, Rahul Saini, Savita Saini, Poonam Coshic, Aditi Sinha, Pankaj Hari, Jayanth Kumar Palanichamy, Arvind Bagga
BACKGROUND: The etiology of atypical hemolytic uremic syndrome (aHUS) is unknown in 30-40% of patients. Anti-factor B (FB) antibodies are reported in C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN), though not in aHUS. METHODS: We screened patients < 18-year-old from cohorts of aHUS and C3G/idiopathic IC-MPGN. Anti-FB IgG antibodies were measured by ELISA and confirmed by Western blot. Normative levels were based on antibody levels in 103 healthy blood donors...
January 22, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38222325/bartonella-henselae-infection-mediated-shunt-nephritis
#17
Jennifer Nhan, Shriprasad Deshpande, Craig Futterman, Dong Hyang Kwon, Aadil Kakajiwala
Serum anti-neutrophil cytoplasmic antibody (ANCA) positivity with membranoproliferative pattern on renal biopsy can be due to ANCA-associated vasculitis as well as chronic indolent infections. We present the case of an adolescent boy with congenital heart disease and history of cardiac surgery who presented with severe acute kidney injury requiring hemodialysis. Renal biopsy showed membranoproliferative glomerulonephritis with full-house immunofluorescence pattern. Low serum complements, PR3 ANCA positivity and elevated Bartonella immunoglobulin titers suggested a diagnosis of infective endocarditis-associated glomerulonephritis...
2024: Clinical Nephrology. Case Studies
https://read.qxmd.com/read/38171412/atypical-anti-glomerular-basement-membrane-nephritis-a-case-series-from-the-french-nephropathology-group
#18
JOURNAL ARTICLE
Bertrand Chauveau, Jean-Baptiste Gibier, Jérôme Olagne, Antoine Morel, Selda Aydin, Stephen P McAdoo, Nicolas Viallet, Hélène Perrochia, Emilie Pambrun, Virginie Royal, Nathalie Demoulin, Jean-Louis Kemeny, Carole Philipponnet, Alexandre Hertig, Jean-Jacques Boffa, Emmanuelle Plaisier, Camille Domenger, Isabelle Brochériou, Clément Deltombe, Jean-Paul Duong Van Huyen, David Buob, Candice Roufosse, Thomas Hellmark, Vincent Audard, Fabrice Mihout, Samih H Nasr, Karine Renaudin, Anissa Moktefi, Marion Rabant
RATIONALE & OBJECTIVE: Atypical anti-glomerular basement membrane (GBM) nephritis is characterized by a bright linear immunoglobulin staining along the GBM by immunofluorescence without a diffuse crescentic glomerulonephritis nor serum anti-GBM antibodies by conventional enzyme-linked immunosorbent assay (ELISA). We characterized a series of patients with atypical anti-GBM disease. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Patients identified by the French Nephropathology Group as having atypical anti-GBM nephritis between 2003 and 2022...
January 1, 2024: American Journal of Kidney Diseases
https://read.qxmd.com/read/38142361/clinical-predictors-of-steroid-resistance-in-childhood-nephrotic-syndrome
#19
JOURNAL ARTICLE
Neslihan Cicek, Nurdan Yıldız, Sercin Guven, Mehtap Kaya, Ibrahim Gokce, Harika Alpay
We aimed to evaluate the clinical parameters, histopathological findings of nephrotic syndrome (NS) patients, and independent factors predicting steroid resistance in a single tertiary center. One hundred and sixty-two children (57 girls and 105 boys) with NS who were followed between 1998 and 2018 were analyzed in this retrospective cohort. The median (interquartile range; range) age and follow-up time were 4.9 (5.7; 0.1-16.8) and 5.5 (5.4; 0.1-20.3) years. A total of 82.7% of the patients were steroid-sensitive nephrotic syndrome (SSNS) and 17...
December 24, 2023: Clinical Pediatrics
https://read.qxmd.com/read/38137694/idiopathic-nephrotic-syndrome-in-children-in-chad-epidemiology-and-clinical-outcomes
#20
JOURNAL ARTICLE
Guillaume Mahamat Abderraman, Youssouf Djidita Hagré, Hissein Ali Mahamat, Senoussi Charfadine, Ali Sakine Amne, Adoum Attimer Khadidja, Lionel Rostaing
INTRODUCTION: Nephrotic syndrome (NS) remains the most common presentation of glomerular diseases in children. Moreover, NS is primarily idiopathic, accounting for 90% of cases, with an average onset age between 2 and 10 years. The objective of our study was to describe the characteristics and outcomes of NS in children from three major hospitals in one of the world's poorest countries, Chad. PATIENTS AND METHODS: This observational, cross-sectional, descriptive, and multicenter study took place over a period of 36 months (1 January 2019-31 December 2021) and was carried out in three hospitals in N'Djamena, Chad...
December 11, 2023: Journal of Clinical Medicine
keyword
keyword
1434
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.